Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
12,153 total articles
Protagonist Therapeutics' CEO, Dinesh V. Patel, executed a substantial sale of common stock valued at approximately $7.5 million on May 12, 2026. This transaction followed the exercise of vested stock options under a pre-arranged Rule 10b5-1 plan. The timing is notable as Protagonist Therapeutics (NASDAQ:PTGX) shares are trading near their 52-week …
Abhinav A. Shukla, Chief Technical Officer at Shattuck Labs, Inc., recently sold a block of company shares. This sale occurred against the backdrop of significant stock performance for Shattuck Labs (NASDAQ:STTK) over the past year and positive assessments regarding its drug candidate SL-325 from TD Cowen.
Andrew Bialecki, Co-Chief Executive Officer and director of Klaviyo, Inc. (NASDAQ:KVYO), recently reported a significant stock sale worth approximately $2.92 million on May 12, 2026. This transaction was executed through a prearranged Rule 10b5-1 trading plan. The report details Bialecki's holdings and provides context regarding the company's recen…
Chairman Sardar Biglari, through his associated funds, executed a significant purchase of Biglari Holdings Inc. (BH) Class B common stock between May 12 and May 14, 2026. The buying spree totaled over $13 million for 52,674 shares, occurring shortly after the stock experienced a notable decline. This insider activity takes place against a backdrop …
Multiple key stakeholders, including North Run Strategic Opportunities Fund I, LP, director Thomas B. Ellis, and member Todd B. Hammer, sold a total of 293,052 shares of LightPath Technologies' Class A Common Stock between May 12 and May 14, 2026, netting approximately $3.57 million. This selling activity occurs following substantial gains for the …
Recent SEC filings reveal that Maciej Kurzymski, Chief Accounting Officer of Bloom Energy Corp., engaged in notable stock transactions. The sale of over $1.8 million in Class A Common Stock occurred amidst strong market performance and subsequent analyst upgrades following the company's recent quarterly report.
Arundathy N. Pandite, Chief Medical Officer at Shattuck Labs, Inc., recently executed a sale of company stock through a prearranged trading plan. This transaction occurred amidst significant stock appreciation and positive developments regarding the company's lead drug candidate. Furthermore, TD Cowen has maintained a Buy rating for Shattuck Labs f…
James H. Litinsky, the chairman and CEO of MP Materials Corp., executed multiple sales totaling approximately $19.6 million worth of shares over two days in May 2026. These transactions occurred while the company's stock was trading below recent highs. Despite the insider selling activity, MP Materials recently reported strong first-quarter financi…
Linkhome Holdings Inc.'s (NASDAQ:LHAI) recent filings reveal significant insider activity involving CEO and Chairman Zhen Qin, who disposed of common stock through private transfers in January and March 2026. These transactions occurred at a price notably higher than the current market valuation. Separately, the company announced a definitive agree…
The Chief Financial Officer of GSI Technology Inc., Douglas Schirle, recently sold 40,000 shares of common stock. This transaction occurred following his acquisition of an equal number of shares through the exercise of vested options. These movements take place as GSI Technology reports mixed financial results for fiscal year 2026, noting revenue i…
Ping Tak Wu, a Vice President at GSI Technology Inc., executed a sale of common stock shares. This transaction occurred after the company's stock experienced significant gains over the previous week and a substantial increase over the past year. Furthermore, recent earnings reports showed revenue growth for both Q4 fiscal 2026 and the full fiscal y…
Fairfax Financial Holdings Ltd. and its Chief Executive Officer, Prem Watsa, acquired a combined total of 44,179,216 Class A Common Shares of Under Armour Inc. over three days in May 2026. These purchases occurred while the stock was trading at levels significantly below some valuation estimates, despite recent negative market reactions to the comp…
A recent SEC filing disclosed that Candace Jackson, a Senior Vice President at Silvaco Group, sold common stock. This transaction occurred against a backdrop of the company's first-quarter fiscal 2026 earnings report, which showed revenue growth but missed analyst expectations for earnings per share (EPS). The firm also announced an expansion of it…
The reported transaction details show that the spouse of GSI Technology's CEO sold a portion of acquired shares. This activity occurs against a backdrop of significant recent stock gains and mixed financial results, including increased annual revenue but a quarterly net loss per share. Investors are evaluating these factors to determine future valu…
A director at Intrepid Potash, Inc. executed a stock sale totaling $217,149. This transaction occurs as the company's shares have seen significant appreciation over six months. Meanwhile, Intrepid Potash released first-quarter 2026 financial results that substantially beat analyst expectations across both earnings per share and revenue.
Robert J. Park, Senior Vice President and Chief Financial Officer of Dolby Laboratories, Inc., sold shares of Class A Common Stock on May 12, 2026. This sale was executed through a pre-arranged Rule 10b5-1 trading plan. The report also details the company's recent Q2 2026 earnings, which surpassed both revenue and EPS forecasts.
Keith A. Meister, a director at Illumina, Inc., recently reported selling approximately $47.9 million worth of common stock over May 13 and May 14, 2026. These transactions were executed through investment funds, while simultaneously, the Corvex Funds completed complex equity swap settlements. The reporting period coincided with strong market activ…
A director at Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR), recently sold a portion of the company's common stock. This activity occurred alongside positive financial disclosures for the second quarter of fiscal year 2026, where both revenue and earnings surpassed analyst forecasts. Despite strong operational performance reported in Q2 2026, the c…
Diana L. Day, Sempra's Chief Legal Counsel, executed a pre-scheduled sale of company stock totaling $304,029. This transaction occurred as the company reported first-quarter 2026 results, showing adjusted EPS slightly above expectations but revenue falling below analyst forecasts. The analysis reviews these insider activities alongside key financia…
Michael Kerr, General Counsel at Q2 Holdings (QTWO), conducted a sale of company stock totaling $17,857. This transaction occurred as QTWO's share price approaches its 52-week low and despite recent mixed financial results reported for the first quarter of 2026. Despite falling short on earnings per share expectations, Q2 Holdings raised its full-y…
QuantumScape director Jeffrey Straubel recently sold a portion of his common stock through a prearranged trading plan. This transaction occurred against the backdrop of recent corporate news, including the company reporting first quarter 2026 earnings that surpassed analyst expectations. The report details both the insider selling activity and the …
The Chief Executive Officer of AAON, Inc., Matthew Tobolski, recently sold substantial amounts of company stock through both indirect trusts and direct transactions. This activity occurs against a backdrop of strong recent corporate performance, including first-quarter earnings that surpassed expectations and an associated increase in the full-year…
Texas Instruments' director, Carrie Smith Cox, recently sold a substantial amount of company stock. This activity occurred while the company's shares are trading close to their 52-week peak, coinciding with recent positive reports from multiple analysts regarding strong earnings performance and robust free cash flow outlook. The sale was notable gi…
A director at AAON, Inc., recently sold a substantial amount of common stock after exercising options. This transaction occurred against a backdrop of robust financial reporting for the first quarter of 2026, where both revenue and earnings significantly surpassed analyst expectations. Following these positive results, the company upgraded its full…
Thomas Catinazzo, CFO of Relay Therapeutics, Inc., sold a reported value of $227,840 worth of common stock. This transaction occurred against a backdrop of significant analyst optimism regarding the company's oncology pipeline and drug developments. The analysis highlights both the insider activity and the positive professional sentiment surroundin…
